SCHEMBL4650760

SCHEMBL4650760

N=C(N)NCCC[C@H](C(N)=O)N(Cc1ccc(O)cc1)C(=O)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 1/20 0.41
▸ NPY4R P50391 9/20 0.39
▸ NPY5R Q15761 6/20 0.39
▸ NPY1R P25929 6/20 0.39
▸ NPY2R P49146 3/20 0.39
▸ CHRNA1 P02708 2/20 0.39
▸ CHRNG P07510 2/20 0.39
▸ CHRNB1 P11230 2/20 0.39
▸ CHRND Q07001 2/20 0.39
▸ REN P00797 1/20 0.38
▸ BCHE P06276 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ FNTA P49354 1/20 0.37
▸ FNTB P49356 1/20 0.37
▸ GRIA1 P42261 1/20 0.37
▸ EPOR P19235 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9201861 0.94 TRPV1 (0.41) TRPV1NPY4RNPY5RNPY1RNPY2R
SCHEMBL8122077 0.90 EPOR (0.39) TRPV1NPY4RNPY5RNPY1RNPY2R
SCHEMBL8525688 0.90 NPY4R (0.38) NPY4RNPY5RNPY1RNPY2R
SCHEMBL8112500 0.89 PLAAT3 (0.44) TRPV1NPY4RNPY5RNPY1RNPY2R
SCHEMBL8113566 0.88 HDAC3 (0.45) TRPV1NPY4RNPY5RNPY1RNPY2R
SCHEMBL8119426 0.87 HDAC3 (0.47) TRPV1NPY4RNPY5RNPY1RNPY2R
SCHEMBL4651754 0.86 NPY4R (0.39) TRPV1NPY4RNPY5RNPY1RNPY2R
SCHEMBL8127572 0.86 HDAC3 (0.40) NPY4RNPY5RNPY1RNPY2RCHRNA1
SCHEMBL1593414 0.84 NPY1R (0.42) NPY4RNPY5RNPY1RNPY2R
SCHEMBL8118604 0.84 NPY4R (0.38) NPY4RNPY5RNPY1RNPY2REPOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007077333-A2 USE OF A NEUROPEPTIDE Y ANTAGONIST FOR DAMAGED OR SENSITIVE LIPS L'OREAL (FR) 2007-07-12 — — WO claimed
EP-0680469-B1 AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME BOEHRINGER INGELHEIM PHARMA (DE) 2000-04-26 — — EP claimed
EP-1093803-B1 Cosmetic composition comprising an antagonist of the neuropeptide Y receptor SANOFI AVENTIS (FR) 2008-09-17 — — EP disclosed
WO-2007077333-A2 USE OF A NEUROPEPTIDE Y ANTAGONIST FOR DAMAGED OR SENSITIVE LIPS L'OREAL (FR) 2007-07-12 — — WO disclosed
EP-0838217-B1 Cosmetic composition containing neuropeptide Y receptor antagonist SANOFI SYNTHELABO (FR) 2003-01-15 — — EP disclosed
EP-1132463-A2 Cosmetic composition comprising an antagonist of the neuropeptide Y receptor SANOFI-SYNTHELABO (FR) 2001-09-12 — — EP disclosed
EP-1093803-A2 Cosmetic composition comprising antagonist of the neuropeptide Y receptor SANOFI-SYNTHELABO (FR) 2001-04-25 — — EP disclosed
EP-0680469-B1 AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME BOEHRINGER INGELHEIM PHARMA (DE) 2000-04-26 — — EP disclosed
EP-0838217-A2 Cosmetic composition containing neuropeptide Y receptor antagonist SANOFI (FR) 1998-04-29 — — EP disclosed
Send feedback